Traders should monitor for potential downward pressure on the stock, especially if no offsetting positive news emerges. The concentration of sales among top executives suggests a lack of confidence in near-term upside or an effort to diversify after a run-up. Consider this a warning sign ahead of earnings or clinical updates.
Price Chart
Executive Summary
Seven executives at Tarsus Pharmaceuticals, including the CEO, COO, and CMO, sold shares in a coordinated open-market cluster over three days, realizing $2.6 million in total proceeds. The sales occurred at prices between $66.75 and $68.71, with the largest individual transaction coming from the CEO, who sold over $1.6 million worth of stock. This represents a material insider selling event involving key leadership.
Key Financial Metrics
Key Facts
- CEO Bobak Azamian sold $1.6 million in shares over two days (11,964 shares at $67 and 11,667 at $68.71).
- All seven insiders involved were C-suite executives, including COO, CCO, CMO, GC, CHRO, and CEO.
- Total cluster value: $2.6 million in open-market sales over 7 days.
- Average sale price: ~$67.50 per share, near recent highs.
- Total value represents ~0.1% of TARS's $2.7B market cap — significant for insider activity.
Financial Impact
$2.6 million in insider sales over 7 days, primarily by C-suite executives
Risk Factors
- Perceived insider pessimism could erode investor confidence.
- Further selling by other insiders may follow.
- Stock may face headwinds if no fundamental catalysts emerge to justify valuation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (15 trades, 7d window) | cluster-TARS-1774386373155 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $82.77 $77.64 | ▼ −6.20% | ▼ −5.54% | $73.09 (−11.70%) |
Sep 3, 2026 29d ago | Insider Cluster | $83.21 $79.31 | ▼ −4.68% | ▼ −3.53% | $73.09 (−12.16%) |
Sep 2, 2026 29d ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.09 (+11.68%) |
Sep 1, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.09 (+11.68%) |
Aug 19, 2026 6w ago | 144 | $73.44 $70.65 | ▼ −3.80% | ▼ −3.41% | $73.09 (−0.48%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.09 (+11.88%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.09 (+11.88%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.09 (+11.88%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.09 (+11.88%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.09 (+11.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access